Where does Vanadis Diagnostics rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Vanadis Diagnostics ranks #20,586 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Vanadis Diagnostics hold?

Vanadis Diagnostics holds 14 US utility patents granted between 2019 and 2025, spanning 7 technology areas.

What is Vanadis Diagnostics's Innovation Score?

Vanadis Diagnostics has an Innovation Score of 30.1 out of 100 (33rd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Vanadis Diagnostics's patent grant rate increasing or decreasing?

Vanadis Diagnostics's recent grant velocity is +125% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Vanadis Diagnostics's patents?

Vanadis Diagnostics's patents average 17.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Vanadis Diagnostics patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Vanadis Diagnostics

Q: What technology areas does Vanadis Diagnostics focus on?

Vanadis Diagnostics's top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 13 patents, ranking #353 of 2,502 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

USPTO PatentsView assignee record - 14 granted patents across 7 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Vanadis ranks #20,586 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 7 technology areas.

#20,586
of 49,997 US assignees by volume: 33rd percentile
by Innovation Score (30.1/100): 17.0
avg claims per patent: +125%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20586 · Foreign Corporation #20,586 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 14 grants
MID-PACK #20,586/49,997
PHOTO-FINISH Uniweld Products
CPC-NARROW C12Q · 7 areas
INNOV-THIN 30.1/100
CLAIMS-RICH 17.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +125% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Uniweld Products, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Vanadis’s 30.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.4 pts (31%) Velocity 1.2 pts (4%) Breadth 9.4 pts (31%) Claim depth 10.2 pts (34%)

Qualcomm Incorporated · highest

85
Vanadis Diagnostics · this assignee

30
3D Lighting… · lowest

7

What this shows Vanadis's Innovation Score is 30.1/100 (33rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Vanadis?

Each dot is one of Vanadis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Vanadis’s own 17.0 claims/patent is ABOVE the 16.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Vanadis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Vanadis's grants concentrate

Vanadis Diagnostics is a focused PatentsView assignee: 7 CPC subclasses with 92.9% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2020 (5 grants) versus a trough of 1 in 2022. By volume, Vanadis sits between Uniweld Products, Inc. and Vesuvius Crucible Company.

Vanadis's three-year grant acceleration

Vanadis Diagnostics shows 2 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Uniweld Products

14
Upsher-smith Labo…

14
Vade Secure

14
Val-chum Partners…

14
Vaon

14
Verint Systems UK

14
Versa Power Syste…

14
Vesuvius Crucible

14
Vanadis Diagnosti… ◀

14

What this shows Vanadis holds 14 patents at rank #20,579, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Vanadis

By rank, the assignees closest to #20,579 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Vanadis's primary technology class.

Vanadis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 33rd percentile higher than 33% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Vanadis Diagnostics patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	4	28.6%
2020	5	35.7%
2021	2	14.3%
2022	1	7.1%
2023	1	7.1%
2025partial year	1	7.1%

Which technologies does Vanadis Diagnostics patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 13

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 3

C08L - Compositions OF Macromolecular Compounds 2

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 1

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 1

B01D - Separation 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Vanadis Diagnostics's patent record in context - here's where to go next.

Vanadis Diagnostics's lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 92.9% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #20,586 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Vanadis Diagnostics against Uniweld Products, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.